Repeat isolates and apparent trends in multidrug-resistant organism detection: a retrospective analysis of aggregated hospital surveillance data using an isolate-to-patient ratio

Background Routine hospital reports of multidrug-resistant organisms (MDROs) often count every isolate, whereas surveillance standards count each patient once. Infection prevention teams that work from monthly aggregate reports cannot remove duplicates themselves. We examined whether repeat isolates from the same patient distorted the apparent trend in MDRO detection and whether the distortion could be measured from aggregate counts alone. Methods We retrospectively analyzed 32 consecutive monthly surveillance reports (January 2024–August 2026) from a 1,200-bed general hospital in China, harmonized to one set of definitions. Repeat isolation was measured with the isolate-to-patient ratio (IPR; key MDRO isolates per MDRO-positive patient), which could be calculated from March 2025, and was monitored with a u -chart. For March–August 2025 versus March–August 2026 we compared isolate-based and patient-based MDRO densities per 1,000 patient-days and standardized the 2026 isolate-based proportion to the 2025 IPR. Results For January–August, the isolate-based MDRO proportion rose from 13.9% in 2024 to 19.4% in 2026 ( P for trend < 0.001). Between the two March–August periods, isolate-based density rose by 31% (rate ratio 1.31; 95% confidence interval [CI] 1.14–1.50) and patient-based density by 11% (rate ratio 1.11; 95% CI 0.93–1.33); the IPR rose from 1.60 to 1.89 (ratio 1.18; 95% CI 1.05–1.33). The IPR exceeded its upper control limit in May–July 2026, during an intensive care unit cluster of carbapenem-resistant Klebsiella pneumoniae (CRKP) in which three patients with bloodstream infection yielded 18 isolates in one month. Standardization to the 2025 IPR removed about half of the between-year difference in the isolate-based proportion (49%–59%, depending on the method). The rise in CRKP persisted in seasonally adjusted sensitivity analyses; the incidence of healthcare-associated infection caused by MDROs did not change measurably. Conclusions Counting every isolate exaggerated an increase in MDROs: about half of the apparent rise reflected more isolates per patient rather than more patients. Where patient-level deduplication is not at hand, the IPR can be calculated from two counts in a routine report, and charting it marks the months in which repeat culturing and clustering both need review. The approach was tested in one hospital and should be validated against patient-level first-isolate data.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-18
DOI
https://doi.org/10.21203/rs.3.rs-11301594/v1
Primary Topic
Infection Control in Healthcare
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Repeat isolates and apparent trends in multidrug-resistant organism detection: a retrospective analysis of aggregated hospital surveillance data using an isolate-to-patient ratio

Shizhen Zheng, Lijia Xiang, Mingqin Gu, Weiyu Zhang et al.
3 links
Research Square
Infection Control in Healthcare
preprint

Repeat isolates and apparent trends in multidrug-resistant organism detection: a retrospective analysis of aggregated hospital surveillance data using an isolate-to-patient ratio

Shizhen Zheng, Lijia Xiang, Mingqin Gu, Weiyu Zhang, Lan Zheng
preprint en

Abstract

Background Routine hospital reports of multidrug-resistant organisms (MDROs) often count every isolate, whereas surveillance standards count each patient once. Infection prevention teams that work from monthly aggregate reports cannot remove duplicates themselves. We examined whether repeat isolates from the same patient distorted the apparent trend in MDRO detection and whether the distortion could be measured from aggregate counts alone. Methods We retrospectively analyzed 32 consecutive monthly surveillance reports (January 2024–August 2026) from a 1,200-bed general hospital in China, harmonized to one set of definitions. Repeat isolation was measured with the isolate-to-patient ratio (IPR; key MDRO isolates per MDRO-positive patient), which could be calculated from March 2025, and was monitored with a u -chart. For March–August 2025 versus March–August 2026 we compared isolate-based and patient-based MDRO densities per 1,000 patient-days and standardized the 2026 isolate-based proportion to the 2025 IPR. Results For January–August, the isolate-based MDRO proportion rose from 13.9% in 2024 to 19.4% in 2026 ( P for trend < 0.001). Between the two March–August periods, isolate-based density rose by 31% (rate ratio 1.31; 95% confidence interval [CI] 1.14–1.50) and patient-based density by 11% (rate ratio 1.11; 95% CI 0.93–1.33); the IPR rose from 1.60 to 1.89 (ratio 1.18; 95% CI 1.05–1.33). The IPR exceeded its upper control limit in May–July 2026, during an intensive care unit cluster of carbapenem-resistant Klebsiella pneumoniae (CRKP) in which three patients with bloodstream infection yielded 18 isolates in one month. Standardization to the 2025 IPR removed about half of the between-year difference in the isolate-based proportion (49%–59%, depending on the method). The rise in CRKP persisted in seasonally adjusted sensitivity analyses; the incidence of healthcare-associated infection caused by MDROs did not change measurably. Conclusions Counting every isolate exaggerated an increase in MDROs: about half of the apparent rise reflected more isolates per patient rather than more patients. Where patient-level deduplication is not at hand, the IPR can be calculated from two counts in a routine report, and charting it marks the months in which repeat culturing and clustering both need review. The approach was tested in one hospital and should be validated against patient-level first-isolate data.

Research Square
Sichuan University (CN), West China Second University Hospital of Sichuan University (CN), Chengdu Second People's Hospital (CN), Second Affiliated Hospital of Chengdu University of Traditional Chinese (CN)
Good health and well-being
Infection Control in Healthcare
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon